Greene, Stephen J.
Tan, Xi
Yeh, Yu-Chen
Bernauer, Mark
Zaidi, Omer
Yang, Mei
Butler, Javed
Funding for this research was provided by:
Merck Sharp and Dohme
Article History
Accepted: 6 January 2021
First Online: 20 January 2021
Compliance with ethical standards
:
: Stephen J. Greene has received a Heart Failure Society of America/ Emergency Medicine Foundation Acute Heart Failure Young Investigator Award funded by Novartis; has received research support from the American Heart Association, Amgen, AstraZeneca, Bristol-Myers Squibb, Merck, and Novartis; has served on advisory boards for Amgen and Cytokinetics; and serves as a consultant for Amgen and Merck. Xi Tan and Mei Yang are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and stockholders of Merck & Co., Inc., Kenilworth, NJ, USA. Yu-Chen Yeh, Mark Bernauer, and Omer Zaidi are employees of Pharmerit, which received research support from Merck & Co., Inc. to conduct the study. Javed Butler serves as a consultant to Abbott, Array, Amgen, Applied Therapeutics, Astra Zeneca, Bayer, Boehringer Ingelheim, CVRx, Eli Lilly, G3 Pharma, Impulse Dynamics, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Sequana Medical, V-Wave Limited, and Vifor.